SG131101A1 - Methods for providing oxidatively stable ophthalmic compositions - Google Patents

Methods for providing oxidatively stable ophthalmic compositions

Info

Publication number
SG131101A1
SG131101A1 SG200606814-2A SG2006068142A SG131101A1 SG 131101 A1 SG131101 A1 SG 131101A1 SG 2006068142 A SG2006068142 A SG 2006068142A SG 131101 A1 SG131101 A1 SG 131101A1
Authority
SG
Singapore
Prior art keywords
methods
providing
ophthalmic compositions
oxidatively stable
stable ophthalmic
Prior art date
Application number
SG200606814-2A
Other languages
English (en)
Inventor
Azaam Alli
Shivkumar Mahadevan
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of SG131101A1 publication Critical patent/SG131101A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0005—Degasification of liquids with one or more auxiliary substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0036—Flash degasification
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0073—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0073—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042
    • B01D19/0078—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042 by vibration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D7/00—Sublimation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D7/00—Sublimation
    • B01D7/02—Crystallisation directly from the vapour phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG200606814-2A 2005-09-30 2006-09-29 Methods for providing oxidatively stable ophthalmic compositions SG131101A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/241,313 US20070077303A1 (en) 2005-09-30 2005-09-30 Methods for providing oxidatively stable ophthalmic compositions

Publications (1)

Publication Number Publication Date
SG131101A1 true SG131101A1 (en) 2007-04-26

Family

ID=37619526

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200606814-2A SG131101A1 (en) 2005-09-30 2006-09-29 Methods for providing oxidatively stable ophthalmic compositions

Country Status (11)

Country Link
US (2) US20070077303A1 (ja)
EP (1) EP1769834A3 (ja)
JP (1) JP2007099768A (ja)
KR (1) KR20070037415A (ja)
CN (1) CN1939278A (ja)
AR (1) AR057526A1 (ja)
AU (1) AU2006225174B2 (ja)
BR (1) BRPI0604723A (ja)
CA (1) CA2561676A1 (ja)
SG (1) SG131101A1 (ja)
TW (1) TW200730468A (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007109523A2 (en) * 2006-03-17 2007-09-27 Johnson & Johnson Vision Care, Inc. Stabilized ophthalmic compositions comprising oxidatively unstable components
CA2648115C (en) 2006-03-31 2015-03-24 Vistakon Pharmaceuticals, Llc Ocular allergy treatments
WO2008151019A1 (en) * 2007-05-30 2008-12-11 University Of Florida Research Foundation, Inc. Extended release of bioactive molecules from silicone hydrogels
AU2010325632B2 (en) * 2009-12-03 2014-01-30 Lupin Limited Process for preparing pharmaceutical ophthalmic compositions
BR112014004637A2 (pt) * 2011-08-31 2017-03-14 Johnson & Johnson Vision Care lente de menisco líquido com formulação de solução salina aprimorada
KR101703980B1 (ko) * 2013-12-30 2017-02-08 주식회사 삼양바이오팜 항산화제를 함유하지 않는 약학 조성물 및 그의 제조방법
KR101919436B1 (ko) * 2015-05-28 2018-11-16 주식회사 삼양바이오팜 안정화된 약학 조성물 및 그의 제조방법
GR1008942B (el) * 2015-10-14 2017-02-06 ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "INTERMED ΑΒΕΕ" Μεθοδος παραγωγης σταθερου υδατικου διαλυματος λυσινικης ιμπουπροφαινης για ενδοκολπικη χρηση
CN108686252B (zh) * 2018-06-11 2021-05-18 深圳英凡妮生物科技有限公司 一种以壳聚糖-泊洛沙姆为基质的纳米银抗菌敷料及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639576A (en) * 1968-06-19 1972-02-01 Barnes Hind Pharm Inc Resterilizing contact lens solution
BE901885A (fr) * 1985-03-06 1985-07-01 Bruschettini Srl Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation.
US4931225A (en) * 1987-12-30 1990-06-05 Union Carbide Industrial Gases Technology Corporation Method and apparatus for dispersing a gas into a liquid
US4853088A (en) * 1988-04-12 1989-08-01 Marathon Oil Company Solar enhanced separation of volatile components from a liquid
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv History 11-) 4-Pipridinyl (-Imidazo] B-1, 2 [] 3 [Benzazepine, their preparation and pharmaceutical preparations containing them
IT1258781B (it) * 1992-01-16 1996-02-29 Zambon Spa Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
JPH07286027A (ja) * 1994-04-19 1995-10-31 Hoya Corp 眼装着用レンズ材料及びそれを用いた眼装着用レンズ
US5597519A (en) * 1994-06-10 1997-01-28 Johnson & Johnson Vision Products, Inc. Ultraviolet cycling oven for polymerization of contact lenses
US5922249A (en) * 1995-12-08 1999-07-13 Novartis Ag Ophthalmic lens production process
JP3689900B2 (ja) * 1998-08-19 2005-08-31 ニプロ株式会社 医療用成形品
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US20020037897A1 (en) * 2000-08-07 2002-03-28 3-Dimensional Pharmaceuticals, Inc. Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
WO2002100436A2 (en) * 2001-06-08 2002-12-19 Novartis Ag Ophthalmic once-a-day composition
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
US20060100408A1 (en) * 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
DE20217473U1 (de) * 2002-11-11 2003-03-27 Analysen Service GmbH Umwelt- und Öllabor Leipzig, 04277 Leipzig Entgasungsmodul für Fluidproben
JP2005124809A (ja) * 2003-10-23 2005-05-19 Sanyo Chem Ind Ltd 医療用接着剤
FR2894154B1 (fr) * 2005-12-06 2008-03-14 Pharmatop Scr Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation.

Also Published As

Publication number Publication date
AU2006225174A1 (en) 2007-04-19
JP2007099768A (ja) 2007-04-19
CA2561676A1 (en) 2007-03-30
EP1769834A2 (en) 2007-04-04
AU2006225174B2 (en) 2012-07-05
KR20070037415A (ko) 2007-04-04
US20070077303A1 (en) 2007-04-05
BRPI0604723A (pt) 2007-08-28
CN1939278A (zh) 2007-04-04
EP1769834A3 (en) 2009-10-07
TW200730468A (en) 2007-08-16
AR057526A1 (es) 2007-12-05
US20110201596A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
GB2424581B (en) Formulations
EP1906776A4 (en) TOBACCO COMPOSITIONS
ZA200801773B (en) New formulation
TWI370115B (en) New formulation
AP2008004547A0 (en) Petsticidal compositions
ZA200706622B (en) Microimplants for ocular administration
GB0503337D0 (en) Compositions
EP1877042A4 (en) BIOLOGICALLY IMPROVED COMPOSITIONS
EP1844702A4 (en) OPHTHALMOLOGICAL INSTRUMENT
IL186390A0 (en) Deodorizing compositions for biowast
EP1909584A4 (en) PRENYLFLAVONOID FORMULATIONS
GB0501192D0 (en) Stable prostaglandin-containing compositions
GB0526283D0 (en) Compositions
GB0501365D0 (en) Compositions
SG131101A1 (en) Methods for providing oxidatively stable ophthalmic compositions
IL185773A0 (en) Formulations
GB0524128D0 (en) Compositions
HK1127998A1 (zh) 含有氧化不穩定組分的穩定的眼用組合物
SG131102A1 (en) Methods for stabilizing ophthalmic compositions
EP1905453A4 (en) CONSERVATORY COMPOSITION FOR OPHTHALMIC USE
GB2433117B (en) Histostain composition for an endoscope
GB0526282D0 (en) Compositions
GB0501364D0 (en) Compositions
GB0506065D0 (en) Compositions
GB0514219D0 (en) Microbiocidal composition